Another Independent Director Resigns From DHFL’s Board
A second Independent director quit Dewan Housing Finance Corporation Ltd.'s board in less than a month as the mortgage lender battles concerns stemming from Cobrapost's allegations of financial irregularities.
VK Chopra submitted his resignation on March 11, according to the letter filed with Ministry of Corporate Affairs. “In view of the recent developments like drastic fall in credit rating of the company as also the same being under credit watch, sizable erosion in market capitalisation and market perception, I wish to resign from the position of independent director of Dewan Housing Finance Corporation,” the resignation letter said.
The mortgage lender has accepted his resignation the same day, it said in an exchange filing. The company said it's in the process of appointing new independent directors and reconstituting the board committee, which it shall announce by March 31.
Chopra's exit follows Vijaya Sampath's resignation as independent director. That comes as the company faces scrutiny after Cobrapost's report. BloombergQuint's investigation also found how money lent by Dewan Housing Finance found its way into firms connected to the Wadhawan family—the promoters of the housing finance company.
Chopra's current term as an independent director was due to end on March 31, the filing said. The resolution for his re-appointment, which was passed by the shareholders on March 4, shall be ineffective in view of his resignation, it said. Chopra had joined DHFL as an independent director in May 2008.
After the resignation of Chopra and Sampath, DHFL's board now has two independent directors. Of the total four directors, while two are independent directors, the other two being promoters—Kapil Wadhawan and Dheeraj Wadhawan.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.